1,510
Views
3
CrossRef citations to date
0
Altmetric
Short Communication

Overcoming the imatinib-resistant BCR-ABL mutants with new ureidobenzothiazole chemotypes endowed with potent and broad-spectrum anticancer activity

, , , , , , , & show all
Article: 2189097 | Received 22 Dec 2022, Accepted 04 Mar 2023, Published online: 17 Mar 2023